(See the editorial commentary by Wortmann on pages 1156-8}Background. Pentavalent antimony is the agent recommended for treatment of cutaneous leishmaniasis (CL). Its use is problematic, because it is expensive and because of the potential for drug-associated adverse effects during a lengthy and painful treatment course.
Methods.We tested the efficacy of thermotherapy for the treatment of CL due to Leishmania tropica in a randomized, controlled trial in Kabul, Afghanistan. We enrolled 4DI patients with a single CL lesion and administered thermotherapy using radio-frequency waves (I treatment of ""I consecutive application at 5D°C for 3D s) or sodium stibogluconate (SSG), administered either intralesionally (a total of 5 injections of 2-5 mL every 5-7 days, depending on lesion size) or intramuscularly (2D mg/kg daily for 2I days).Results. Cure, defined as complete reepithelialization at I 00 days after treatment initiation, was observed in 75 ( 69.4%) of IDS patients who received thermotherapy, 70 (75.3%) of 93 patients who received intralesional SSG, and 26 (44.8%) of 58 patients who received intramuscular SSG. The OR for cure with thermotherapy was 2.8D